Clinical guide
Relapse in Addiction: Signs, Stages, Causes, and Prevention
Learn relapse signs, stages, causes, overdose risk after abstinence, and evidence-based prevention steps for recovery.
By Paul James Roeser·Reviewed by Noelle Mathew, LCSW, LCADC, CASAC-M·Last reviewed August 25, 2026·10 min read
Published ·Updated
Relapse is the return to substance use after a period of abstinence, and in a chronic condition it is a recorded clinical event rather than proof that treatment failed. The National Institute on Drug Abuse puts the relapse rate for substance use disorders at 40 to 60 percent, alongside 50 to 70 percent for hypertension and 50 to 70 percent for asthma.
Relapse is also a sequence with a measurable shape. Federal relapse-prevention guidance describes warning patterns before substance use returns: addictive behavior, addictive thinking, emotional buildup, high-risk situations, and the coping response that follows. Prevention work acts on that sequence before a return to use becomes physical.
What Is A Relapse?
Clinical perspective
Relapse almost never starts on the day it happens — it starts weeks earlier, with the routines that stopped, the check-ins that got shorter, the isolation that crept back in. By the time the substance is back in someone's hand, the actual relapse has usually been underway for a while. That's why the pattern leading up to it matters more than the moment itself.
A relapse is a return to uncontrolled substance use after abstinence, and a lapse is the initial drink or drug use. Melemis reports that some researchers divide physical relapse this way, and notes that one use may quickly lead to uncontrolled use. The distinction still decides what happens next: a lapse triggers a review of the plan, and a relapse triggers a reassessment of the level of care.
Both terms describe behavior rather than character, and the language a clinical record uses carries consequences for the person in it. Relapse belongs to the natural history of substance use disorder in the same way that a rise in blood pressure belongs to the natural history of hypertension. The condition is chronic, the treatment is episodic, and the gap between those two facts is what produces a return to use. How wide that gap runs in practice is measurable.
How Common Is Relapse After Addiction Treatment?
Relapse affects 40 to 60 percent of people treated for a substance use disorder. The National Institute on Drug Abuse publishes that figure for comparison with other chronic illnesses. Those comparisons are close enough that the difference in how each condition is judged looks like a matter of stigma rather than medicine.
The 3 conditions below are the comparison NIDA draws, and the rates are the ones it publishes for each.
| Condition | Rate of return to symptoms after treatment | How a return is treated clinically |
| Substance use disorder | 40 to 60 percent | Reassessment of the treatment plan and the level of care |
| Hypertension | 50 to 70 percent | Adjustment of medication and behavioral plan |
| Asthma | 50 to 70 percent | Adjustment of controller therapy and trigger management |
Timescale matters as much as rate. Dennis, Michael and Scott, Christy K. reported in their 2007 paper "Managing addiction as a chronic condition" in Addiction Science and Clinical Practice that in a longitudinal cohort of 1,271 patients, the median time from first substance use to at least one drug-free year was 27 years, and the median time from a first treatment episode to a first alcohol-free and drug-free year was 9 years, across three to four episodes of different kinds of treatment. In the same work, the odds of moving from use to recovery rose by a factor of 1.14 for every 9 weeks of treatment received during a year. Those numbers describe a long arc with repeated re-entry inside it, which is the shape a single relapse sits within.
What Are The Stages Of Relapse?
Relapse can be tracked through 3 practical stages: emotional relapse, mental relapse, and physical relapse. Emotional relapse erodes self-care before any thought of using appears, mental relapse places craving in conflict with commitment, and physical relapse is the return to use itself.
Emotional relapse shows up as bottled-up emotion, isolation, skipped meetings, and neglected physical health, with no intention to use present. Mental relapse opens an internal argument: part of the person wants to use and part does not, and the signs are craving, thinking about people and places attached to past use, minimizing consequences, bargaining, and planning. Physical relapse is the act of using. The 3 stages of relapse require different responses: restore routines during emotional relapse, disclose craving and planning during mental relapse, and reassess safety and care after physical relapse.
What Are The Early Warning Signs Of Relapse?
Five early warning signs of relapse are withdrawal from support, abandoned self-care, minimized consequences, renewed contact with substance-use cues, and unreported craving. Each appears before physical relapse rather than after it.
The 5 signs below map onto the emotional and mental stages, and each is visible to a person's clinician, family or peers before it is acted on.
- Withdrawal from support, including cancelled therapy appointments, missed peer meetings and avoided contact with family.
- Abandoned self-care, including disrupted sleep, skipped meals, stopped exercise and neglected hygiene.
- Minimizing past consequences, including retelling the history of use with the harm edited out of it.
- Returning contact with cues, including renewed contact with people, places and routines attached to past use.
- Unreported craving, including craving that a person stops disclosing to a clinician or sponsor.

Relapse warning signs include observable changes in behavior, thinking, physical health, and recovery participation. The signs reveal what is changing; assessment identifies the mechanisms underneath.
What Causes A Relapse?
Four recurring relapse mechanisms are stress, conditioned environmental cues, untreated psychiatric conditions, and treatment contact or medication ending too soon. Each acts on the same reward and stress circuitry that the substance itself acted on.
SAMHSA TIP 35 identifies high-risk situations, cravings, cognitive traps, emotional distress, social cues, and ineffective coping responses as modifiable parts of relapse prevention. Stress matters because it can intensify craving and narrow the choices a person sees in the moment; treatment therefore pairs trigger planning with coping skills, support, and a written relapse-management response.
The 4 mechanisms below account for the recorded pathways back to use. When anxiety, depression, trauma symptoms, sleep disturbance, or substance-induced psychiatric symptoms change the safety or treatment decision, integrated outpatient mental health care is a clinically relevant part of relapse prevention.
- Stress raises craving and degrades the regulatory response that would otherwise contain it.
- Conditioned cues reinstate craving through people, places, objects and routines paired with past use.
- Untreated psychiatric conditions return a person to the substance as a means of managing symptoms that nothing else is managing.
- Withdrawn treatment contact removes the monitoring and medication that were holding the plan in place.
One consequence of a return to use is more dangerous than the rest, and it arrives in the first hours.
Why Does Overdose Risk Rise After A Relapse?
Overdose risk rises after relapse because tolerance falls during abstinence, a previously tolerated dose can suppress breathing when use resumes, and opioids can cause fatal respiratory depression. The remembered dose may remain the same while the body's tolerance has changed.
Call 911 immediately for any suspected overdose. Call Poison Help at 1-800-222-1222 for any ingestion or overdose. The over-the-counter NARCAN label directs a bystander to give a dose for a suspected overdose and to stay until the ambulance arrives even if the person wakes up. Naloxone temporarily reverses opioid-induced respiratory depression, but emergency evaluation remains necessary because its effect may end before the opioid effect does.
The size of the risk has been measured directly in a population that experiences forced abstinence followed by sudden availability. Binswanger, Ingrid A. and colleagues reported in their 2007 study Release from prison, a high risk of death for former inmates in the New England Journal of Medicine that in the first two weeks after release, the risk of death was 12.7 times that of other state residents, and the risk of death from drug overdose was 129 times that of other state residents. The mechanism is the same one that operates after any period of abstinence: tolerance falls, the remembered dose does not, and the margin between them disappears. That is the specific harm relapse prevention exists to remove.
Which Relapse-Prevention Methods Have Evidence Behind Them?
Structured relapse prevention and mindfulness-based relapse prevention have randomized-trial evidence in the research cited here. Each targets a different part of the sequence, from the erosion of self-care through to the reinstatement of craving.
Bowen, Sarah and colleagues tested the first two directly in their 2014 randomized clinical trial in JAMA Psychiatry. They assigned 286 people who had completed inpatient or intensive outpatient treatment to an 8-week aftercare program of mindfulness-based relapse prevention, standard relapse prevention or treatment as usual. At 6 months, both mindfulness-based and standard relapse prevention produced a significantly lower risk of relapse to substance use and heavy drinking than treatment as usual. At 12 months, the mindfulness-based arm reported significantly fewer days of substance use and significantly less heavy drinking than either comparison.

The 5 actions below convert those findings into a plan a person can hold.
- Name the specific triggers in writing, listing the people, places, times and emotional states that preceded past use.
- Schedule the clinical contact rather than leaving it to be arranged after a bad week.
- Continue prescribed medication for opioid or alcohol use disorder for the duration the prescriber set, not the duration that feels sufficient.
- Protect sleep, food and movement, since erosion of those three is the observable start of emotional relapse.
- Tell one person early, because craving that goes unreported is the one warning sign a clinician cannot act on.
A plan written before a bad week is worth more than a decision taken during one, which is also true of the hours immediately after a relapse has already happened.
What Are The First Steps After A Relapse Happens?
The first 24 hours after relapse call for 5 actions: assess medical risk, tell the treating clinician, restart treatment at the reassessed level of care, remove the remaining supply, and return to peer support.
The 5 steps below run in sequence, and each one produces information the next step depends on.
- Get a medical assessment the same day when the amount used, the substance or the length of abstinence created overdose risk.
- Contact the treating clinician and report the amount, the substance and the interval since the last use.
- Reenter treatment at the level of care the reassessment supports, which is decided by current risk rather than by prior treatment history.
- Remove the remaining supply and the immediate access route to more of it.
- Return to peer support within the same week rather than waiting for a clean stretch first.
Reentry is a clinical step rather than a restart from zero. An addiction treatment reassessment evaluates withdrawal, medical risk, psychiatric symptoms, recurrence risk, and recovery supports before setting the next level of care.
Recovery from addiction continues after immediate reassessment through ongoing treatment, medication when indicated, peer or family support, and a written response plan for new warning signs.
What Are The Most Common Questions About Relapse?
The 6 questions below cover whether relapse means treatment failed, when relapse is most likely, whether progress is lost, medication, family response, and how relapse differs across substances.
Does A Relapse Mean Treatment Failed?
No. NIDA frames a return to use in substance use disorder the way clinicians frame a return of symptoms in hypertension or asthma: as a signal to adjust the treatment plan. The failure would be leaving the plan unadjusted.
When Is Relapse Most Likely To Happen?
The highest-risk window follows any break in treatment contact, and the highest-risk window for fatal overdose follows any extended period of abstinence, because tolerance falls while the remembered dose does not.
Does A Relapse Erase The Progress Already Made?
No. Dennis and Scott recorded sustained recovery arriving across three to four episodes of treatment rather than one, and measured rising odds of moving from use to recovery with every additional 9 weeks of treatment received.
Do Medications Reduce Relapse Risk?
Yes, for opioid and alcohol use disorder. Buprenorphine, methadone and naltrexone are approved for opioid use disorder, and naltrexone, acamprosate and disulfiram for alcohol use disorder. Stopping them without a prescriber's plan restores the risk they were reducing.
How Can Family Respond To A Relapse?
Treat overdose risk first, then reporting. Call 911 for any suspected overdose and Poison Help at 1-800-222-1222 for any ingestion. Once the person is safe, the useful action is contacting the treating clinician rather than negotiating alone.
Does Relapse Look The Same For Every Substance?
The three-stage sequence holds across substances. The consequences do not. Opioid relapse after abstinence carries the highest immediate mortality risk, because respiratory depression follows a dose that was survivable before tolerance fell.
Sources & References8ShowHide
- NIDA. Drugs, Brains, and Behavior: The Science of Addiction, Treatment and Recovery — Source of the 40 to 60 percent relapse rate for substance use disorders and the 50 to 70 percent comparison rates for hypertension and asthma.
- Dennis M, Scott CK. Managing addiction as a chronic condition. Addiction Science and Clinical Practice, 2007;4(1):45-55 — Source of the 27-year median from first use to a first drug-free year, the 9-year median from first treatment, the three to four treatment episodes, the cohort of 1,271 patients, and the 1.14 odds ratio per 9 weeks of treatment received.
- Binswanger IA, Stern MF, Deyo RA, et al. Release from prison, a high risk of death for former inmates. New England Journal of Medicine, 2007;356(2):157-165 — Source of the relative risk of death of 12.7 in the first two weeks after release and the relative risk of death from drug overdose of 129, both against other state residents.
- Bowen S, Witkiewitz K, Clifasefi SL, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry, 2014;71(5):547-556 — Source of the 286-participant aftercare trial, the 6-month result for both prevention arms against treatment as usual, and the 12-month advantage of the mindfulness-based arm.
- SAMHSA. Treatment Options for Substance Use Disorder — Current federal guidance on medication, counseling, behavioral therapies, recovery, and opioid overdose reversal medications.
- SAMHSA. TIP 35: Enhancing Motivation for Change in Substance Use Disorder Treatment — Federal relapse-prevention guidance on high-risk situations, coping responses, craving management, and relapse-management planning.
- CDC. Assess Risks and Potential Harms of Opioid Use — Current clinical guidance on lost opioid tolerance, return to a previously tolerated dose, and naloxone risk mitigation.
- SAMHSA. RecoverMe: Substance Use and Mental Health — Federal guidance on the relationship between substance use, mental health symptoms, stress, trauma, and recovery support.